Pharma and CCS Consulting SRL
Pharma and CCS Consulting reported total assets of 456,254 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
By total assets for 2025, Pharma and CCS Consulting ranks among the 20,000 largest of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Pharma and CCS Consulting shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +112 % Total assets +98 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma and CCS Consulting's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 15 Jul 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
- Year ended 31 Dec 2022filed on 25 Jul 2023
Pharma and CCS Consulting's financial analysis
- Solvency90.5%sector median: 50.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma and CCS Consulting
Pharma and CCS Consulting's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0772.858.683
- VAT number
- BE0772858683
- Peppol
- Registered · 0208:0772858683 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Aug 2021
- Registered office
- 4053 Chaudfontaine
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Pharma and CCS Consulting (SRL) has been based in Chaudfontaine since 2021, active in: business and other management consultancy activities. For 2025, it reports a net profit of 94,244 € and equity of 412,706 €; its revenue is not published. Its solvency stands at 90.5%, above the median of its sector (50.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharma and CCS Consulting
Companies in the same business, of comparable size and area, outside its group.
- MiTiBel Business and other management consultancy activities Lochristi · balance sheet 62,393 €
- Segers Healthcare Consultancy Services Business and other management consultancy activities Keerbergen · balance sheet 550,932 €
- Lotek Business and other management consultancy activities Ottignies-Louvain-la-Neuve · balance sheet 610,915 €
- Jplconsult Business and other management consultancy activities Gerpinnes · balance sheet 336,848 €
- ADSA Business and other management consultancy activities Ixelles · balance sheet 398,524 €
- IMES Business and other management consultancy activities Saint-Gilles · balance sheet 32,114 €
- SERFAN innovation Business and other management consultancy activities Namur · balance sheet 478,912 €
- DA Consult Business and other management consultancy activities Thimister-Clermont · balance sheet 893,266 €
Frequently asked questions about Pharma and CCS Consulting
What is the revenue of Pharma and CCS Consulting?
Pharma and CCS Consulting files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma and CCS Consulting?
In Belgium, the VAT number is the company number prefixed with BE: BE0772858683 for Pharma and CCS Consulting, if the company is VAT-registered. Its company number (CBE) is 0772.858.683.
Where is the registered office of Pharma and CCS Consulting?
According to the CBE register, the registered office of Pharma and CCS Consulting is in 4053 Chaudfontaine.
What is the equity of Pharma and CCS Consulting?
At the close of the 2025 financial year, the equity of Pharma and CCS Consulting amounts to 412,706 €, a solvency of 90.5% of total assets.
Who manages Pharma and CCS Consulting?
The register lists 2 active mandates at Pharma and CCS Consulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Pharma and CCS Consulting within its sector?
By total assets for 2025, Pharma and CCS Consulting ranks among the 20,000 largest of the 50,410 companies in its sector (NACE 7020) in Belgium that filed accounts for that financial year.
The full file of Pharma and CCS Consulting
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →